首页> 外国专利> P-GP RADIOTRACERS FOR IMAGING AS BIOMARKER INVOLVED IN ONSET OF NEURODEGENERATIVE DISEASES

P-GP RADIOTRACERS FOR IMAGING AS BIOMARKER INVOLVED IN ONSET OF NEURODEGENERATIVE DISEASES

机译:P-GP放射性示踪剂,可作为涉及神经退行性疾病发病的生物标记物进行成像

摘要

The invention includes a new class of radiolabeled compounds of formula I able to bind P-glycoprotein with high affinity and selectivity. The protein prevents accumulation in the brain of a wide range of drugs and, changes in P-gp expression and function, are also believed to occur in several neurological disorder, such as Alzheimer's disease (AD). Indeed, it is widely reported that decreased expression of P- gp and/or activity at the BBB level could cause accumulation of I3- amyloid plaques, the main hallmark of AD onset. 13-amyloid is a P-gp substrate, and these results support the importance of P-gp in the clearance of 13-amyloid peptide from brain parenchyma. For this reason, P-gp can be considered a useful biomarker for the early diagnosis of neurodegeneration. There is considerable interest in the development of P-gp PET radiotracers for imaging expression and function of P-gp. Formula I wherein the compound is labeled with an isotope selected from H, 11C14C, 13N, 150 18F19F, 75Br, 76Br, 79Br.
机译:本发明包括一类新的放射性标记的式I化合物,其能够以高亲和力和选择性结合P-糖蛋白。该蛋白质可防止多种药物在大脑中蓄积,并且据信P-gp表达和功能的变化也发生在几种神经系统疾病中,例如阿尔茨海默氏病(AD)。确实,广泛报道了BBB水平P-gp表达降低和/或活性降低可能导致I3-淀粉样斑块的积累,这是AD发作的主要标志。 13-淀粉样蛋白是P-gp的底物,这些结果支持P-gp在清除脑实质中13-淀粉样蛋白肽方面的重要性。因此,可以将P-gp视为早期诊断神经变性的有用生物标记。对用于成像表达和功能的P-gp PET放射性示踪剂的研究引起了极大的兴趣。其中化合物用选自H,11 C 14 C, 13 N,150 18 F < / Sub> 19 F, 75 Br, 76 Br, 79 Br。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号